======= ETS2 =======
== Gene Information ==
* **Official Symbol**: ETS2
* **Official Name**: ETS proto-oncogene 2, transcription factor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2114|2114]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P15036|P15036]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ETS2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ETS2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/164740|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcription factor activating transcription. Binds specifically the DNA GGAA/T core motif (Ets-binding site or EBS) in gene promoters and stimulates transcription. {ECO:0000269|PubMed:11909962}.
|SAM PNT|
|Ets|
|ectodermal cell fate commitment|
|ectoderm formation|
|ectodermal cell differentiation|
|primitive streak formation|
|glucocorticoid receptor binding|
|ectoderm development|
|cell fate commitment involved in formation of primary germ layer|
|gastrulation with mouth forming second|
|anterior/posterior axis specification|
|axis specification|
|formation of primary germ layer|
|mesoderm development|
|gastrulation|
|anterior/posterior pattern specification|
|protein domain specific binding|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|cell fate commitment|
|regionalization|
|pattern specification process|
|skeletal system development|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|embryonic morphogenesis|
|DNA-binding transcription factor activity|
|negative regulation of transcription by RNA polymerase II|
|anatomical structure formation involved in morphogenesis|
|embryo development|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|tissue development|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp331|A-769662 20μM R07 exp331]]|-1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|1/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18461
* **Expression level (log2 read counts)**: 7.18
{{:chemogenomics:nalm6 dist.png?nolink |}}